These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3457996)

  • 1. Unresponsiveness of bone to PTH in aluminum-related renal osteodystrophy.
    Kawaguchi Y; Oda Y; Imamura N; Shigematu T; Kimura Y; Aizawa S; Fujimaki H; Shoji R; Tsukui I; Ogura Y
    Kidney Int Suppl; 1986 Feb; 18():S49-52. PubMed ID: 3457996
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.
    Goodman WG; Duarte ME
    Miner Electrolyte Metab; 1991; 17(4):221-32. PubMed ID: 1813784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum: toxin or innocent bystander in renal osteodystrophy.
    Malluche HH; Faugere MC
    Am J Kidney Dis; 1985 Nov; 6(5):336-41. PubMed ID: 3904426
    [No Abstract]   [Full Text] [Related]  

  • 4. Aluminum and renal osteodystrophy in chronic uremia.
    Berland Y; Grandvuillemin M; Charhon S; Olmer M
    Kidney Int Suppl; 1985 Dec; 17():S183-7. PubMed ID: 3867793
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone.
    Chesney RW; Mehls O; Anast CS; Brown E; Hammerman MR; Portale A; Fallon MD; Mahan J; Alfrey AC
    Am J Kidney Dis; 1986 Apr; 7(4):275-84. PubMed ID: 3515907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium/phosphate imbalances, aluminum toxicity, and renal osteodystrophy.
    Brunier GM
    ANNA J; 1994 Jun; 21(4):171-7; quiz 178-9. PubMed ID: 8080326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal osteodystrophy].
    Pols HA; Birkenhäger-Frenkel DH; Birkenhäger JC
    Ned Tijdschr Geneeskd; 1991 Jul; 135(27):1213-7. PubMed ID: 1861752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of PTH, 1,25(OH)2D3 and biochemistry in renal osteodystrophy].
    Jia JK; Lou DX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):33-6. PubMed ID: 8045186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum: culprit or accessory in the genesis of renal osteodystrophy.
    Quarles LD; Gitelman HJ; Drezner MK
    Semin Nephrol; 1986 Mar; 6(1):90-101. PubMed ID: 3299578
    [No Abstract]   [Full Text] [Related]  

  • 11. Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism.
    Pizzarelli F; Ballanti P; Costantini S; Mocetti P; Giordano R; Della Rocca C; Fabrizi F; Bonucci E; Maggiore Q
    Miner Electrolyte Metab; 1988; 14(2-3):129-34. PubMed ID: 3380068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic effects of parathyroid hormone metabolites: implications for renal bone disease.
    Akhtar I; González EA
    J Investig Med; 2004 Jan; 52(1):51-7. PubMed ID: 14989370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminium-induced bone disease in uremic rats: effect of deferoxamine.
    Jablonski G; Klem KH; Danielsen CC; Mosekilde L; Gordeladze JO
    Biosci Rep; 1996 Feb; 16(1):49-63. PubMed ID: 8861540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH.
    Ritz E; Malluche HH; Krempien B; Tschope W; Massry SG
    Adv Exp Med Biol; 1978; 103():423-36. PubMed ID: 362849
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonal changes in and therapy of renal osteodystrophy].
    Löcsey L; Kakuk G; Szabó T; Wórum I; Nagy Z; Leövey A
    Orv Hetil; 1980 Aug; 121(35):2121-7. PubMed ID: 7465173
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of calcium and phosphorus in hemodialysis.
    Goldsmith RS
    Annu Rev Med; 1976; 27():181-90. PubMed ID: 180871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone stimulates dentin and bone apposition in the thyroparathyroidectomized rat in a dose-dependent fashion.
    Turnbull RS; Heersche JN; Tam CS; Howley TP
    Calcif Tissue Int; 1983 Jul; 35(4-5):586-90. PubMed ID: 6616323
    [No Abstract]   [Full Text] [Related]  

  • 19. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy.
    Marie PJ; Lomri A; de Vernejoul MC; Morieux C; Graulet AM; Guéris J; Llach F
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1166-73. PubMed ID: 2555383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.